Our Active Projects and Spinouts
Protein to Protein Interaction Drug - Fission Bio
Fission Bio is developing a protein-protein interaction inhibitor drug that cuts the link between chronic inflammation and mitochondrial dysfunction to treat multiple age-related and neurodegenerative diseases to extend human lifespan.
$200k
Enhancing Protein Translation to Combat Neurodegeneration - Project Transfidelity
Project Transfidelity aims to enhance the accuracy of protein synthesis to prevent the misfolding and aggregation associated with neurodegenerative diseases like Alzheimer's.
$425k+
Combating Memory Loss and Cognitive Decline - Percepta®
Percepta® is a patent-protected brain health natural dietary supplement (active ingredients, PTI-00703® Cat’s claw and MemorTea® - a specific oolong tea extract).
$500k+
Small Molecule Modulator for Tremors and Ataxia - SK-Channels
The SK-channels project is developing a small molecule positive allosteric modulator drug for small-conductance calcium-activated potassium (SK) channels for the treatment of ataxia and related tremors, with a potential for other CNS and peripheral indications.
$65,000
Treatments for Alzheimer's and Inflammatory Skin Conditions - AT-001
Arctic Therapeutics focuses on creating innovative treatments for neurodegenerative and inflammatory skin diseases. Their lead candidates: AT-001, targets dementia and Alzheimer's, and AT-004, aims to treat inflammatory skin conditions like acne vulgaris.
€75k
Are you driving the next big breakthrough in neuroscience?
CerebrumDAO provides the financial support, incubation and a collaborative network dedicated to advancing brain science.
